Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study

Aims: Better prediction of outcome after total hip arthroplasty (THA) is warranted. Systemic inflammation and central neuroinflammation are possibly involved in progression of osteoarthritis and pain. We explored whether inflammatory biomarkers in blood and cerebrospinal fluid (CSF) were associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Morten R. Blichfeldt-Eckhardt, Claus Varnum, Jørgen T. Lauridsen, Lasse E. Rasmussen, Winnie C. P. Mortensen, Hanne I. Jensen, Henrik B. Vaegter, Kate L. Lambertsen
Format: Article
Language:English
Published: The British Editorial Society of Bone & Joint Surgery 2024-12-01
Series:Bone & Joint Research
Subjects:
Online Access:https://online.boneandjoint.org.uk/doi/epdf/10.1302/2046-3758.1312.BJR-2024-0103.R1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583712241352704
author Morten R. Blichfeldt-Eckhardt
Claus Varnum
Jørgen T. Lauridsen
Lasse E. Rasmussen
Winnie C. P. Mortensen
Hanne I. Jensen
Henrik B. Vaegter
Kate L. Lambertsen
author_facet Morten R. Blichfeldt-Eckhardt
Claus Varnum
Jørgen T. Lauridsen
Lasse E. Rasmussen
Winnie C. P. Mortensen
Hanne I. Jensen
Henrik B. Vaegter
Kate L. Lambertsen
author_sort Morten R. Blichfeldt-Eckhardt
collection DOAJ
description Aims: Better prediction of outcome after total hip arthroplasty (THA) is warranted. Systemic inflammation and central neuroinflammation are possibly involved in progression of osteoarthritis and pain. We explored whether inflammatory biomarkers in blood and cerebrospinal fluid (CSF) were associated with clinical outcome, and baseline pain or disability, 12 months after THA. Methods: A total of 50 patients from the Danish Pain Research Biobank (DANPAIN-Biobank) between January and June 2018 were included. Postoperative outcome was assessed as change in Oxford Hip Score (OHS) from baseline to 12 months after THA, pain was assessed on a numerical rating scale, and disability using the Pain Disability Index. Multiple regression models for each clinical outcome were included for biomarkers in blood and CSF, respectively, including age, sex, BMI, and Kellgren-Lawrence score. Results: Change in OHS was associated with blood concentrations of tumour necrosis factor (TNF), interleukin-8 (IL-8), interleukin-6 receptor (IL-6R), glycoprotein 130 (gp130), and IL-1β (R2 = 0.28, p = 0.006), but not with CSF biomarkers. Baseline pain was associated with blood concentrations of lymphotoxin alpha (LTα), TNFR1, TNFR2, and IL-6R (R2 = 0.37, p < 0.001) and CSF concentrations of TNFR1, TNFR2, IL-6, IL-6R, and IL-1Ra (R2 = 0.40, p = 0.001). Baseline disability was associated with blood concentrations of TNF, LTα, IL-8, IL-6, and IL-1α (R2 = 0.53, p < 0.001) and CSF concentrations of gp130, TNF, and IL-1β (R2 = 0.26, p = 0.002). Thus, preoperative systemic low-grade inflammation predicted 12-month postoperative outcome after THA, and was associated with preoperative pain and disability. Conclusion: This study highlights the importance of systemic inflammation in osteoarthritis, and presents a possible path for better patient selection for THA in the future. Preoperative central neuroinflammation was associated with preoperative pain and disability, but not change in OHS after THA. Cite this article: Bone Joint Res 2024;13(12):741–749.
format Article
id doaj-art-463d684a0f26427ea98f253e9b6a722e
institution Kabale University
issn 2046-3758
language English
publishDate 2024-12-01
publisher The British Editorial Society of Bone & Joint Surgery
record_format Article
series Bone & Joint Research
spelling doaj-art-463d684a0f26427ea98f253e9b6a722e2025-01-28T06:54:06ZengThe British Editorial Society of Bone & Joint SurgeryBone & Joint Research2046-37582024-12-01131274174910.1302/2046-3758.1312.BJR-2024-0103.R1Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative studyMorten R. Blichfeldt-Eckhardt0https://orcid.org/0000-0002-7759-5642Claus Varnum1https://orcid.org/0000-0002-0625-5691Jørgen T. Lauridsen2https://orcid.org/0000-0001-9889-6236Lasse E. Rasmussen3https://orcid.org/0000-0003-1277-3193Winnie C. P. Mortensen4https://orcid.org/0000-0002-9659-7125Hanne I. Jensen5https://orcid.org/0000-0001-9323-4284Henrik B. Vaegter6https://orcid.org/0000-0002-7707-9947Kate L. Lambertsen7https://orcid.org/0000-0001-9276-4902Department of Anesthesiology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, DenmarkDepartment of Regional Health Research, University of Southern Denmark, Odense, DenmarkDepartment of Economics, University of Southern Denmark, Odense, DenmarkDepartment of Orthopaedic Surgery, Lillebaelt Hospital - Vejle, University Hospital of Southern Denmark, Vejle, DenmarkDepartment of Anesthesiology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, DenmarkDepartment of Anesthesiology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, DenmarkPain Research Group, Department of Anesthesiology and Intensive Care Medicine, Odense University Hospital, Odense, DenmarkDepartment of Neurology, Odense University Hospital, Odense, DenmarkAims: Better prediction of outcome after total hip arthroplasty (THA) is warranted. Systemic inflammation and central neuroinflammation are possibly involved in progression of osteoarthritis and pain. We explored whether inflammatory biomarkers in blood and cerebrospinal fluid (CSF) were associated with clinical outcome, and baseline pain or disability, 12 months after THA. Methods: A total of 50 patients from the Danish Pain Research Biobank (DANPAIN-Biobank) between January and June 2018 were included. Postoperative outcome was assessed as change in Oxford Hip Score (OHS) from baseline to 12 months after THA, pain was assessed on a numerical rating scale, and disability using the Pain Disability Index. Multiple regression models for each clinical outcome were included for biomarkers in blood and CSF, respectively, including age, sex, BMI, and Kellgren-Lawrence score. Results: Change in OHS was associated with blood concentrations of tumour necrosis factor (TNF), interleukin-8 (IL-8), interleukin-6 receptor (IL-6R), glycoprotein 130 (gp130), and IL-1β (R2 = 0.28, p = 0.006), but not with CSF biomarkers. Baseline pain was associated with blood concentrations of lymphotoxin alpha (LTα), TNFR1, TNFR2, and IL-6R (R2 = 0.37, p < 0.001) and CSF concentrations of TNFR1, TNFR2, IL-6, IL-6R, and IL-1Ra (R2 = 0.40, p = 0.001). Baseline disability was associated with blood concentrations of TNF, LTα, IL-8, IL-6, and IL-1α (R2 = 0.53, p < 0.001) and CSF concentrations of gp130, TNF, and IL-1β (R2 = 0.26, p = 0.002). Thus, preoperative systemic low-grade inflammation predicted 12-month postoperative outcome after THA, and was associated with preoperative pain and disability. Conclusion: This study highlights the importance of systemic inflammation in osteoarthritis, and presents a possible path for better patient selection for THA in the future. Preoperative central neuroinflammation was associated with preoperative pain and disability, but not change in OHS after THA. Cite this article: Bone Joint Res 2024;13(12):741–749.https://online.boneandjoint.org.uk/doi/epdf/10.1302/2046-3758.1312.BJR-2024-0103.R1inflammagingneuroinflammationtotal hip arthroplastyoxford hip scorepostoperative outcometotal hip arthroplasty (tha)osteoarthritis (oa)inflammationbiomarkersbloodinterleukin 6tumour necrosis factoroxford hip score (ohs)interleukin-8glycoprotein
spellingShingle Morten R. Blichfeldt-Eckhardt
Claus Varnum
Jørgen T. Lauridsen
Lasse E. Rasmussen
Winnie C. P. Mortensen
Hanne I. Jensen
Henrik B. Vaegter
Kate L. Lambertsen
Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study
Bone & Joint Research
inflammaging
neuroinflammation
total hip arthroplasty
oxford hip score
postoperative outcome
total hip arthroplasty (tha)
osteoarthritis (oa)
inflammation
biomarkers
blood
interleukin 6
tumour necrosis factor
oxford hip score (ohs)
interleukin-8
glycoprotein
title Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study
title_full Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study
title_fullStr Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study
title_full_unstemmed Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study
title_short Low-grade systemic inflammation, but not neuroinflammation, is associated with 12-month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis: an explorative study
title_sort low grade systemic inflammation but not neuroinflammation is associated with 12 month postoperative outcome after total hip arthroplasty in patients with painful osteoarthritis an explorative study
topic inflammaging
neuroinflammation
total hip arthroplasty
oxford hip score
postoperative outcome
total hip arthroplasty (tha)
osteoarthritis (oa)
inflammation
biomarkers
blood
interleukin 6
tumour necrosis factor
oxford hip score (ohs)
interleukin-8
glycoprotein
url https://online.boneandjoint.org.uk/doi/epdf/10.1302/2046-3758.1312.BJR-2024-0103.R1
work_keys_str_mv AT mortenrblichfeldteckhardt lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT clausvarnum lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT jørgentlauridsen lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT lasseerasmussen lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT winniecpmortensen lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT hanneijensen lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT henrikbvaegter lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy
AT katellambertsen lowgradesystemicinflammationbutnotneuroinflammationisassociatedwith12monthpostoperativeoutcomeaftertotalhiparthroplastyinpatientswithpainfulosteoarthritisanexplorativestudy